David D. O'Toole - 30 Nov 2023 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: CFO
Signature: /s/ Donna Shiroma
Issuer symbol: RCEL
Transactions as of: 30 Nov 2023
Net transactions value: +$14,709
Form type: 4
Filing time: 04 Dec 2023, 19:06:26 UTC
Previous filing: 21 Nov 2023
Next filing: 12 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award	$9,369	+1,034	+6.9%	$9.06	16,034	30 Nov 2023	Direct	F1
transaction	RCEL	Common Stock	Purchase	$5,340	+500	+3.1%	$10.68	16,534	01 Dec 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period).

Content

These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period).